India Globalization Capital Inc Market Cap ($26.91 Million)
Market Cap & Net Worth: India Globalization Capital Inc (IGC)
India Globalization Capital Inc market cap. India Globalization Capital Inc (NYSE MKT:IGC) has a market capitalization of $26.91 Million ($26.91 Million) as of November 1, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #23978 globally and #5194 in its home market, demonstrating a -3.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying India Globalization Capital Inc's stock price $0.29 by its total outstanding shares 95038026 (95.04 Million). Also see India Globalization Capital Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
India Globalization Capital Inc Market Cap History (2015–2026)
India Globalization Capital Inc market cap history from 2015 to 2026. Data shows growth from $22.81 Million to $27.56 Million (4.60% CAGR). Check India Globalization Capital Inc share price for real-time trading data and today's change.
India Globalization Capital Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how India Globalization Capital Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore IGC net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
20.94x
India Globalization Capital Inc's market cap is 20.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $26.61 Million | $6.37 Million | -$2.81 Million | 4.18x | N/A |
| 2017 | $95.04 Million | $580.37K | -$1.87 Million | 163.75x | N/A |
| 2018 | $26.61 Million | $2.19 Million | -$1.79 Million | 12.13x | N/A |
| 2019 | $59.87 Million | $5.12 Million | -$4.10 Million | 11.70x | N/A |
| 2020 | $148.26 Million | $4.07 Million | -$7.32 Million | 36.41x | N/A |
| 2021 | $93.14 Million | $898.00K | -$8.81 Million | 103.72x | N/A |
| 2022 | $30.41 Million | $397.00K | -$15.02 Million | 76.60x | N/A |
| 2023 | $26.61 Million | $911.00K | -$11.51 Million | 29.21x | N/A |
| 2024 | $31.93 Million | $1.34 Million | -$13.00 Million | 23.74x | N/A |
| 2025 | $26.61 Million | $1.27 Million | -$7.12 Million | 20.94x | N/A |
Competitor Companies of IGC by Market Capitalization
Companies near India Globalization Capital Inc in the global market cap rankings as of November 1, 2026. Also see IGC current and non-current assets for a full breakdown of the balance sheet.
Key companies related to India Globalization Capital Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of India Globalization Capital Inc (2015–2026)
Market capitalization of India Globalization Capital Inc from 2015 to today. Between 2015 and today, India Globalization Capital Inc's market cap moved from $22.81 Million to $ 27.56 Million, with a yearly change of 4.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $27.56 Million | +3.57% |
| 2025 | $26.61 Million | -16.67% |
| 2024 | $31.93 Million | +20.00% |
| 2023 | $26.61 Million | -12.50% |
| 2022 | $30.41 Million | -67.35% |
| 2021 | $93.14 Million | -37.18% |
| 2020 | $148.26 Million | +147.62% |
| 2019 | $59.87 Million | +125.00% |
| 2018 | $26.61 Million | -72.00% |
| 2017 | $95.04 Million | +257.14% |
| 2016 | $26.61 Million | +16.67% |
| 2015 | $22.81 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 1st, 2026 the market cap of India Globalization Capital Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $26.91 Million USD |
| MoneyControl | $26.91 Million USD |
| MarketWatch | $26.91 Million USD |
| marketcap.company | $26.91 Million USD |
| Reuters | $26.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About India Globalization Capital Inc
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops treatments for Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63, IGC-M3, and LMP to treat Alzheimer's disease; IGC-1C for the treatm… Read more